• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LncRNA DLEU2 通过调节细胞周期和 NOTCH 通路促进宫颈癌细胞增殖。

LncRNA DLEU2 promotes cervical cancer cell proliferation by regulating cell cycle and NOTCH pathway.

机构信息

Basic Medical College, Chongqing Medical University, Chongqing, China; Department of Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Basic Medical College, Chongqing Medical University, Chongqing, China.

出版信息

Exp Cell Res. 2021 May 1;402(1):112551. doi: 10.1016/j.yexcr.2021.112551. Epub 2021 Mar 4.

DOI:10.1016/j.yexcr.2021.112551
PMID:33675808
Abstract

Long noncoding RNAs (lncRNAs) are known to play a crucial role in the onset and progression of cervical cancer (CC). Here, the results of RNA microarray and RNA-sequencing dataset analysis showed that lncRNA DLEU2 was significantly upregulated in CC tissues. Clinicopathologic analysis indicated that lncRNA DLEU2 was closely related to tumor topography. Functional experiments and bioinformatics analysis revealed that lncRNA DLEU2 promoted CC cell proliferation and accelerated the cell cycle. Mechanistically, lncRNA DLEU2 promoted the progression of the cell cycle and inhibited the activity of the Notch signaling pathway by inhibiting p53 expression. Additionally, lncRNA DLEU2 probably interacted with ZFP36 Ring Finger Protein (ZFP36) to inhibit the expression of p53. In conclusion, this study revealed the function of lncRNA DLEU2 in CC tumorigenesis, suggesting new therapeutic targets in CC.

摘要

长链非编码 RNA(lncRNAs)在宫颈癌(CC)的发生和发展中起着至关重要的作用。在这里,RNA 微阵列和 RNA 测序数据集分析的结果表明,lncRNA DLEU2 在 CC 组织中显著上调。临床病理分析表明,lncRNA DLEU2 与肿瘤的形态学密切相关。功能实验和生物信息学分析表明,lncRNA DLEU2 促进 CC 细胞增殖并加速细胞周期。机制上,lncRNA DLEU2 通过抑制 p53 表达促进细胞周期的进展并抑制 Notch 信号通路的活性。此外,lncRNA DLEU2 可能与 ZFP36 环指蛋白(ZFP36)相互作用以抑制 p53 的表达。总之,本研究揭示了 lncRNA DLEU2 在 CC 肿瘤发生中的作用,为 CC 的治疗提供了新的靶点。

相似文献

1
LncRNA DLEU2 promotes cervical cancer cell proliferation by regulating cell cycle and NOTCH pathway.LncRNA DLEU2 通过调节细胞周期和 NOTCH 通路促进宫颈癌细胞增殖。
Exp Cell Res. 2021 May 1;402(1):112551. doi: 10.1016/j.yexcr.2021.112551. Epub 2021 Mar 4.
2
Long non-coding RNA, steroid receptor RNA activator (SRA), induces tumor proliferation and invasion through the NOTCH pathway in cervical cancer cell lines.长非编码 RNA、类固醇受体 RNA 激活物(SRA)通过 NOTCH 通路诱导宫颈癌细胞系的肿瘤增殖和侵袭。
Oncol Rep. 2017 Dec;38(6):3481-3488. doi: 10.3892/or.2017.6023. Epub 2017 Oct 11.
3
Long non-coding RNA DLEU2 promotes the progression of esophageal cancer through miR-30e-5p/E2F7 axis.长链非编码 RNA DLEU2 通过 miR-30e-5p/E2F7 轴促进食管癌的进展。
Biomed Pharmacother. 2020 Mar;123:109650. doi: 10.1016/j.biopha.2019.109650. Epub 2019 Dec 26.
4
LncRNA DLEU2 accelerates the tumorigenesis and invasion of non-small cell lung cancer by sponging miR-30a-5p.长链非编码 RNA DLEU2 通过海绵吸附 miR-30a-5p 促进非小细胞肺癌的发生和侵袭。
J Cell Mol Med. 2020 Jan;24(1):441-450. doi: 10.1111/jcmm.14749. Epub 2019 Nov 13.
5
Long non-coding RNA RP11-552M11.4 favors tumorigenesis and development of cervical cancer via modulating miR-3941/ATF1 signaling.长非编码 RNA RP11-552M11.4 通过调节 miR-3941/ATF1 信号促进宫颈癌的发生发展。
Int J Biol Macromol. 2019 Jun 1;130:24-33. doi: 10.1016/j.ijbiomac.2019.02.083. Epub 2019 Feb 18.
6
E2F transcription factor 2-activated DLEU2 contributes to prostate tumorigenesis by upregulating serum and glucocorticoid-induced protein kinase 1.E2F 转录因子 2 激活的 DLEU2 通过上调血清和糖皮质激素诱导的蛋白激酶 1 促进前列腺肿瘤发生。
Cell Death Dis. 2022 Jan 24;13(1):77. doi: 10.1038/s41419-022-04525-1.
7
Long non-coding RNA ZFAS1 is an unfavourable prognostic factor and promotes glioma cell progression by activation of the Notch signaling pathway.长链非编码RNA ZFAS1是一种不良预后因素,通过激活Notch信号通路促进胶质瘤细胞进展。
Biomed Pharmacother. 2017 Mar;87:555-560. doi: 10.1016/j.biopha.2017.01.014. Epub 2017 Jan 9.
8
LncRNA NOC2L-4.1 functions as a tumor oncogene in cervical cancer progression by regulating the miR-630/YAP1 pathway.长链非编码RNA NOC2L-4.1通过调控miR-630/YAP1通路在宫颈癌进展中发挥肿瘤癌基因的作用。
J Cell Biochem. 2019 Oct;120(10):16913-16920. doi: 10.1002/jcb.28949. Epub 2019 May 17.
9
SP1-induced up-regulation of lncRNA LUCAT1 promotes proliferation, migration and invasion of cervical cancer by sponging miR-181a.SP1 诱导的长链非编码 RNA LUCAT1 的上调通过海绵吸附 miR-181a 促进宫颈癌的增殖、迁移和侵袭。
Artif Cells Nanomed Biotechnol. 2019 Dec;47(1):556-564. doi: 10.1080/21691401.2019.1575840.
10
LncRNA DLEU2 is activated by STAT1 and induces gastric cancer development via targeting miR-23b-3p/NOTCH2 axis and Notch signaling pathway.长链非编码RNA DLEU2被信号转导和转录激活因子1激活,并通过靶向miR-23b-3p/Notch2轴和Notch信号通路诱导胃癌发展。
Life Sci. 2021 Jul 15;277:119419. doi: 10.1016/j.lfs.2021.119419. Epub 2021 Mar 27.

引用本文的文献

1
Identification of a disulfidptosis-related genes signature for diagnostic and immune infiltration characteristics in cervical cancer.用于宫颈癌诊断及免疫浸润特征的二硫化物介导的程序性坏死相关基因特征的鉴定
PLoS One. 2025 Apr 30;20(4):e0322387. doi: 10.1371/journal.pone.0322387. eCollection 2025.
2
DLEU2 facilitates bladder cancer progression through miR-103a-2-5p/SOS1 axis.DLEU2通过miR-103a-2-5p/SOS1轴促进膀胱癌进展。
PeerJ. 2025 Apr 8;13:e18995. doi: 10.7717/peerj.18995. eCollection 2025.
3
Cell Cycle-Based Molecular Features via Synthetic Lethality and Non-Coding RNA Interactions in Cancer.
基于细胞周期的分子特征:癌症中合成致死性与非编码RNA相互作用
Genes (Basel). 2025 Mar 5;16(3):310. doi: 10.3390/genes16030310.
4
IRTKS contributes to the malignant progression of cervical cancer cells.IRTKS 促进宫颈癌细胞的恶性进展。
Med Oncol. 2024 Jun 13;41(7):174. doi: 10.1007/s12032-024-02410-9.
5
The mechanisms and diagnostic potential of lncRNAs, miRNAs, and their related signaling pathways in cervical cancer.长链非编码RNA、微小RNA及其相关信号通路在宫颈癌中的作用机制与诊断潜力
Front Cell Dev Biol. 2023 May 4;11:1170059. doi: 10.3389/fcell.2023.1170059. eCollection 2023.
6
Deleted in lymphocytic leukemia 2 (DLEU2): a possible biomarker that holds promise for future diagnosis and treatment of cancer.淋巴细胞白血病 2 号缺失(DLEU2):一种有希望成为癌症未来诊断和治疗的生物标志物。
Clin Transl Oncol. 2023 Oct;25(10):2772-2782. doi: 10.1007/s12094-023-03149-x. Epub 2023 Apr 24.
7
The Role of Long Noncoding RNA (lncRNAs) Biomarkers in Renal Cell Carcinoma.长链非编码 RNA(lncRNAs)标志物在肾细胞癌中的作用。
Int J Mol Sci. 2022 Dec 30;24(1):643. doi: 10.3390/ijms24010643.
8
lncRNA DLEU2 Accelerates Oral Cancer Progression via miR-30a-5p/RAP1B Axis to Regulate p38 MAPK Signaling Pathway.长链非编码 RNA DLEU2 通过 miR-30a-5p/RAP1B 轴促进口腔癌进展,从而调节 p38 MAPK 信号通路。
Dis Markers. 2022 Oct 12;2022:9310048. doi: 10.1155/2022/9310048. eCollection 2022.
9
Notch-associated lncRNAs profiling circuiting epigenetic modification in colorectal cancer.Notch相关长链非编码RNA对结直肠癌表观遗传修饰的调控机制
Cancer Cell Int. 2022 Oct 13;22(1):316. doi: 10.1186/s12935-022-02736-2.
10
Long noncoding RNAs (lncRNAs) in HIV-mediated carcinogenesis: Role in cell homeostasis, cell survival processes and drug resistance.长链非编码RNA(lncRNAs)在HIV介导的致癌作用中的作用:在细胞稳态、细胞存活过程及耐药性中的作用
Noncoding RNA Res. 2022 Jul 31;7(3):184-196. doi: 10.1016/j.ncrna.2022.07.003. eCollection 2022 Sep.